Finalist for the 2015 Extraordinary Healer Award for Oncology Nursing: Elmeria S. Teffeteller, RN, MSN, APRN, AOCN, University of Tennessee Cancer Institute in Knoxville, Tennessee
"No recent cancer advance has been more transformative than immunotherapy," said ASCO president Julie M. Vose.
In an interview with CURE, Philippe Moreau discusses the significance of Ninlaro's approval and the TOURMALINE-MM1 study.
Held each year on Feb. 4, World Cancer Day aims to unite people from around the world to increase awareness of cancer in a positive and inspiring way.
The approval is primarily based on the phase 3 MK-0517-031 study, in which adding single-dose Emend for injection induced a complete response in nearly 80 percent of patients receiving MEC.
Cometriq elicited a statistically significant improvement in survival compared with Afinitor as a treatment for patients with advanced renal cell carcinoma following progression on one prior therapy.
Finalist for the 2015 Extraordinary Healer Award for Oncology Nursing: Beverly M. Moser, RN, BSN, OCN [Rose Quarter Compass Oncology in Portland, Oregon]
The likelihood of developing oropharyngeal cancer was 22 times higher among individuals with detectable human papillomavirus (HPV)-16 in their mouthwash samples.
Winner of the 2015 Extraordinary Healer Award for Oncology Nursing: Laura J. Vasquez, RN, CPON [Children's Hospital Los Angeles (CHLA) in Los Angeles, California]